Electrophysiological characterization of a CaV3.1 calcium channel mutation linked to trigeminal neuralgia

被引:6
|
作者
Alaklabi, Abdulaziz M. M. [1 ,2 ]
Gambeta, Eder [1 ]
Zamponi, Gerald W. W. [1 ]
机构
[1] Univ Calgary, Alberta Childrens Hosp Res Inst, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada
[2] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia
来源
基金
加拿大健康研究院;
关键词
T-type channel; Facial pain; Ion channel; Mutation; Voltage-gated calcium channel; I-II LOOP; SURFACE EXPRESSION; CA2+ CHANNELS; PATHOPHYSIOLOGY; CLASSIFICATION;
D O I
10.1007/s00424-023-02808-w
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Trigeminal neuralgia is a rare and debilitating disorder that affects one or more branches of the trigeminal nerve, leading to severe pain attacks and a poor quality of life. It has been reported that the Ca(V)3.1 T-type calcium channel may play an important role in trigeminal pain and a recent study identified a new missense mutation in the CACNA1G gene that encodes the pore forming alpha 1 subunit of the Ca(V)3.1 calcium channel. The mutation leads to a substitution of an Arginine (R) by a Glutamine (Q) at position 706 in the I-II linker region of the channel. Here, we used whole-cell voltage-clamp recordings to evaluate the biophysical properties of Ca(V)3.1 wild-type and R706Q mutant channels expressed in tsA-201 cells. Our data indicate an increase in current density in the R706Q mutant, leading to a gain-of-function effect, without changes in the voltage for half activation. Moreover, voltage clamp using an action potential waveform protocol revealed an increase in the tail current at the repolarization phase in the R706Q mutant. No changes were observed in the voltage-dependence of inactivation. However, the R706Q mutant displayed a faster recovery from inactivation. Hence, the gain-of-function effects in the R706Q Ca(V)3.1 mutant have the propensity to impact pain transmission in the trigeminal system, consistent with a contribution to trigeminal neuralgia pathophysiology.
引用
收藏
页码:711 / 718
页数:8
相关论文
共 50 条
  • [1] Electrophysiological characterization of a CaV3.1 calcium channel mutation linked to trigeminal neuralgia
    Abdulaziz M. Alaklabi
    Eder Gambeta
    Gerald W. Zamponi
    Pflügers Archiv - European Journal of Physiology, 2023, 475 : 711 - 718
  • [2] Gating of the expressed Cav3.1 calcium channel
    Lacinová, L
    Klugbauer, N
    Hofmann, F
    FEBS LETTERS, 2002, 531 (02) : 235 - 240
  • [3] Roles of molecular domains in the activation of the calcium channel Cav3.1
    Li, JY
    Stevens, L
    Klugbauer, N
    Wray, D
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 271A - 271A
  • [4] Discovery of α-Obscurine Derivatives as Novel Cav3.1 Calcium Channel Blockers
    Wang, Lei
    Li, Wen-Yan
    Yuan, Zai-Feng
    Zhao, Qin-Shi
    CHEMISTRY & BIODIVERSITY, 2024, 21 (04)
  • [5] Cav2.2 and Cav3.1 calcium channel inhibitors from Valeriana jatamansi Jones
    Jiang, He-Hai
    Dong, Wu
    Zhou, Jun
    Hu, Jiang-Miao
    Yang, Jian
    Nian, Yin
    RSC ADVANCES, 2017, 7 (72): : 45878 - 45884
  • [6] Inhibition of Cav3.1 channel by silver ions
    Gromová, P
    Kurejová, M
    Lacinová, L
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2003, 22 (04) : 515 - 523
  • [7] Complex modulation of Cav3.1 T-type calcium channel by nickel
    Olena V. Nosal
    Olga P. Lyubanova
    Valeri G. Naidenov
    Yaroslav M. Shuba
    Cellular and Molecular Life Sciences, 2013, 70 : 1653 - 1661
  • [8] Slow inactivation of the Cav3.1 isoform of the T type calcium channel.
    Hering, J
    Maulet, Y
    Feltz, A
    Lambert, RC
    BIOPHYSICAL JOURNAL, 2001, 80 (01) : 621A - 622A
  • [9] Complex modulation of Cav3.1 T-type calcium channel by nickel
    Nosal, Olena V.
    Lyubanova, Olga P.
    Naidenov, Valeri G.
    Shuba, Yaroslav M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (09) : 1653 - 1661
  • [10] A Small Peptide Inhibitor of the Low Voltage-Activated Calcium Channel Cav3.1
    Chen, Ren-Shiang
    Best, Philip M.
    MOLECULAR PHARMACOLOGY, 2009, 75 (05) : 1042 - 1051